154 A major obstacle in this process lies in the limitations of animal models, which remain indispensable for mechanistic studies and early phase drug screening
The lawsuits claim that Novo Nordisk was aware, or should have been aware, of the potential for these severe side effects but did not provide sufficient warnings to consumers and healthcare professionals
doi: 10.1186/s12933-022-01686-3
Pfizer/Hospira and Fresenius Kabi set the documentation benchmark through FDA-registered cGMP manufacturing with per-lot COAs
Weight regain that arrives as soon as the medication stopsproof that appetite control isnt the same as metabolic correction
In animal models of Alzheimers disease (AD), Parkinsons disease (PD), ischemic stroke, intracerebral hemorrhage (ICH), Huntingtons disease (HD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), depression, epilepsy, and spinal cord injury (SCI), these cellular changes add up to less protein aggregation, less neuron loss, and better functional outcomes